Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Peutz-Jeghers Syndrome × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Skin Neoplasms 3 Kasabach-Merritt Syndrome 2 Kaposiform Hemangioendothelioma 2 Waldenstrom Macroglobulinemia 1 Renal Transplant Patients at High-risk for Skin Cancer 1 Refractory Solid Tumors 1 Peutz-Jeghers Syndrome 1 Neoplasms, Plasma Cell 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leiomyoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangioma 1 Angiomyolipoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03781050 2019-01-23

Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

Peking Union Medical College Hospital

Phase 4 Unknown

Hereditary Sensory and Autonomic Neuropathies, Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡